This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Hooper Holmes To Lead Biological Sample Collection For Landmark Government Tobacco Study

Hooper Holmes (NYSE Amex:HH) has been selected as the biological sample collection lead for the largest government study of tobacco use ever conducted in the United States.

The study is a landmark collaboration between the National Institutes of Health and the U.S. Food and Drug Administration. It is the first large-scale project on tobacco regulatory research since Congress granted FDA the authority to regulate tobacco products in the Family Smoking Prevention and Tobacco Control Act of 2009. Scientific experts at NIH's National Institute on Drug Abuse and the FDA's Center for Tobacco Products will coordinate the effort.

The study is properly known as the Tobacco Control Act National Longitudinal Study of Tobacco Users. Westat, in Rockville, MD., was awarded the research contract by the National Institute on Drug Abuse in a competitive solicitation process and has designated Hooper Holmes as the biological sample collection lead.

Over five years, investigators will follow more than 40,000 users of tobacco products nationwide and those at risk for tobacco use ages 12 and older. Participants will be interviewed annually and biological samples will be collected by Hooper Holmes.

“This five year study draws upon several of our strengths, including our national network of local health professionals and Heritage Labs’ kit manufacturing,” said Ransom J. Parker, President and CEO of Hooper Holmes. “Hooper Holmes is uniquely equipped to support longitudinal research studies and we are proud to have been selected as a partner in the Westat consortium.”

Hooper Holmes will collect buccal cell, urine and blood samples from participants and provide collection kits. Buccal cell samples are samples taken by swabbing the cheek inside the mouth. Collection kits will be manufactured at Hooper Holmes’ Heritage Labs division based in Olathe, KS.

Hooper Holmes will select and train phlebotomists from the Company’s national network of 9,000 local health professionals to collect samples following study protocols.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,813.39 +1.20 0.01%
S&P 500 2,088.87 -0.27 -0.01%
NASDAQ 5,116.1430 +13.3350 0.26%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs